Latest News and Press Releases
Want to stay updated on the latest news?
-
Long-term revenue potential of over $75 million for NME with IP protection through 2031 Leverages existing commercial capabilities to provide a novel treatment option for OIC ...
-
Hermed indkaldes til ordinær generalforsamling i ViroGates A/S den 25. april 2019 kl. 17.00 på Comwell Holte, Kongevejen 495A, 2840 Holte. Dagsorden og fuldstændige forslag kan læses i vedhæftede...
-
HERMÈS Very good sales and performance in 2018Recurring operating profitability amounts to 34.3% of sales Net profit reaches €1.4 billion, up +15% Paris, 20 March 2019 The...
-
MÅ IKKE OFFENTLIGGØRES, DISTRIBUERES ELLER UDLEVERES HELT ELLER DELVIST, DIREKTE ELLER INDIREKTE, I ELLER TIL USA, AUSTRALIEN, CANADA ELLER JAPAN Seluxit indgår samarbejde med distributør om...
-
ÅRSREGNSKABSMEDDELELSE 2018 Omsætning på DKK 1.583 mio. mod DKK 1.333 mio. i 2017. Driftsresultat (EBIT) på DKK 834 mio. mod DKK 768 mio. i 2017. Resultat før kurs- og værdireguleringer (EBVAT) på...
-
New York, NY, Feb. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Telecoms.com (www.telecoms.com), the highly respected and independent news portal covering the latest technological advancements...
-
RALEIGH, N.C., Feb. 04, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
-
RALEIGH, N.C., Jan. 15, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
-
BELBUCA® continued on an accelerated growth trajectory, with revenue increasing 92% YOY and 27% versus prior quarterBELBUCA total prescriptions experienced its largest quarter over quarter increase...
-
More than 100 million Covered Lives Now Have Preferred Access to BELBUCA RALEIGH, N.C., Nov. 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly...